Last Update

2013-01-08T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Yi Shi?

Dr. Yi Shi

Board Observer

NOVAST HOLDINGS LTD

HQ Phone:

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

NOVAST HOLDINGS LTD

1212 Corporate Drive, Suite 123

Irving, Texas 75038

United States

Company Description

Novast Holdings Ltd., is a FDA-inspected multinational pharmaceutical company with business units based in the China and United States. We have a strong focus and proven record on design and development of difficult formulations containing challenging API ... more

Find other employees at this company (9)

Background Information

Employment History

ChinaBio LLC

Managing Director

Lilly Asia Ventures

Management Consultant

Ernst & Young LLP

Affiliations

Board Member
Innovent Biologics , Inc.

Board Member
Beta Pharma

Board Member
Chipscreen Biosciences Co. , Ltd.

Board Member
HD Biosciences Co. Ltd

Board Member
SinqiPharma

Board Member
BrightGene Biomedical

Scientific Operations
InnoCentive Inc

Education

Bachelor of Science

Biology

University of Science and Technology of China

Master of Business Administration degree

Duke University

Ph.D.

Biochemistry

Duke University

Web References (46 Total References)


Yi Shi (Lilly Asia ...

www.innoventbio.com [cached]

Yi Shi (Lilly Asia Ventures) Innovent Biologics, Inc._About Us_Board of Directors

...
Dr. Shi is managing director of Lilly Asian Ventures, andfounding member of InnoCentive, Inc., a Lilly Ventures portfolio company. Based in Shanghai, Yi oversees Lilly Asia Ventures since its founding in 2008. Prior to his current role, Yi worked at Eli Lilly and Company with a diverse set of experiences including venture start-up, marketing, business development licensing, and corporate strategy.Currently, he serves on the Board of HD Bioscience, Chipscreen, Beta Pharma, BrightGene Biomedical, Novast, and SinqiPharma.
Yi's education includes a Ph.D. in biochemistry and a Master of Business Administration degree, both from Duke University. He also earned a Bachelor of Sciences in Biology from the University of Science and Technology of China.
...
Yi Shi (Lilly Asia Ventures)


Dr. Shi is managing director ...

www.innoventbio.com [cached]

Dr. Shi is managing director of Lilly Asian Ventures, andfounding member of InnoCentive, Inc., a Lilly Ventures portfolio company. Based in Shanghai, Yi oversees Lilly Asia Ventures since its founding in 2008. Prior to his current role, Yi worked at Eli Lilly and Company with a diverse set of experiences including venture start-up, marketing, business development licensing, and corporate strategy.Currently, he serves on the Board of HD Bioscience, Chipscreen, Beta Pharma, BrightGene Biomedical, Novast, and SinqiPharma.

Yi's education includes a Ph.D. in biochemistry and a Master of Business Administration degree, both from Duke University. He also earned a Bachelor of Sciences in Biology from the University of Science and Technology of China.
...
Yi Shi (Lilly Asia Ventures)


Yi Shi, Ph.D., Managing ...

www.lillyasianventures.com [cached]

Yi Shi, Ph.D., Managing Director

Based in Shanghai, Yi oversees Lilly Asian Ventures operations and has been instrumental in managing the fund's investments in China since its founding. Prior to his current role, Yi worked at Eli Lilly and Company with a diverse set of experiences including venture start-up, operations, business development licensing, and international strategy. He was a founding member of InnoCentive, Inc., a Lilly Ventures portfolio company. Yi began his career as a management consultant with Ernst & Young in the US, where he specialized in life sciences practice.
Yi's education includes a Ph.D. in Biochemistry and a Master of Business Administration degree, both from Duke University. He also earned a Bachelor of Science in Biology from the University of Science and Technology of China. He is a member of the Board of Directors of HD Biosciences, Chipscreen and Beta Pharma. He also serves as a board observer at Novast and CITIC Pharma.
Photo of Yi Shi


BioCapital China Summit 2009 - Speaker Bios

www.chinabiollc.com [cached]

Yi Shi, PhD - Managing Director, Lilly Asian Ventures

Dr. Yi Shi joined Lilly Asian Ventures in 2007 as a Managing Director based in Shanghai, China. Prior to the current assignment, he worked in various roles with increasing responsibility over six years at Eli Lilly and Company. His experience includes leading the development of a comprehensive investment strategy for China as well as negotiating multiple biotechnology and pre-clinical deals world-wide. Dr. Shi was also instrumental in the founding of InnoCentive, Inc., a Lilly Ventures portfolio company, where he managed scientific operations as well as its expansion into China. Before joining Lilly, Dr. Shi was the Chief Sales and Marketing Officer of NetBig.com, an internet start-up, where he successfully grew the company to become the number one education and technology portal in China. He began his career as a management consultant with Ernst & Young in the Life Science Practice Group and specialized in sales and marketing strategy. Dr. Shi received a Ph.D. in Biochemistry and a Master of Business Administration degree, both from Duke University. He also earned a Bachelor of Science in Biology from the University of Science and Technology of China.


bioBAY Investor Forum 2008 - Suzhou - Speaker Bios

www.chinabiollc.com [cached]

Yi Shi, PhD - Managing Director, Lilly Asian Ventures

Dr. Yi Shi joined Lilly Asian Ventures in 2007 as a Managing Director based in Shanghai, China. Prior to the current assignment, he worked in various roles with increasing responsibility over six years at Eli Lilly and Company. His experience includes leading the development of a comprehensive investment strategy for China as well as negotiating multiple biotechnology and pre-clinical deals world-wide. Dr. Shi was also instrumental in the founding of InnoCentive, Inc., a Lilly Ventures portfolio company, where he managed scientific operations as well as its expansion into China.
Before joining Lilly, Dr. Shi was the Chief Sales and Marketing Officer of NetBig.com, an internet start-up, where he successfully grew the company to become the number one education and technology portal in China. He began his career as a management consultant with Ernst & Young in the Life Science Practice Group and specialized in sales and marketing strategy. Dr. Shi received a Ph.D. in Biochemistry and a Master of Business Administration degree, both from Duke University. He also earned a Bachelor of Science in Biology from the University of Science and Technology of China.

Similar Profiles

Other People with this Name

Other people with the name Shi

Cindy Shi
Shanghai Far East Expeditions Inc

Li Shi
TISIZE

Jeff Shi
DMPK

Yanke Shi
Hebei Yuanda Trade Co. Ltd

Andrew Shi
AIDS Legal Referral Panel

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory